TuHURA Biosciences Inc

Market Cap

$143M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.97+$1.22 (+162.00%)

Jun 5, 2026

52W High $3.2552W Low $0.44

Company Details

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to ove...

CEO

—

IPO Date

Feb 22, 2013

Website

www.tuhurabio.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$31M

EPS (Diluted)

Free Cash Flow

-$27M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q4 2026

Aug 13, 2026

PENDING

Q3 2026

May 15, 2026

Q2 2026

Mar 31, 2026

Q1 2026

Nov 14, 2025

FY 2025

Aug 14, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee